Table 2.
Characteristic | n women reporting exposure, n intervals exposure reported (N = 100 women and 360 intervals) |
Coeff. (95% CI)a | P valuea | Adj Coeff. (95% CI)b | P valueb |
---|---|---|---|---|---|
Self-reported past history of BV | |||||
No | 78, 285 | ref | ref | ||
Yes | 22, 75 | 0.28 (0.06,0.50) | 0.013 | 0.26 (0.04,0.48) | 0.018 |
Longitudinal characteristicsc | |||||
Any smokingd,e | |||||
No | 47, 210 | ref | ref | ||
Yes | 53, 149 | 0.18 (0.01,0.35) | 0.036 | 0.08 (−0.09,0.25) | 0.352 |
Any douchinge | |||||
No | 94, 351 | ref | |||
Yes | 6, 8 | 0.50 (−0.02,1.01) | 0.060 | ||
Number of SP | |||||
0 | 3, 38f | ref | |||
1 | 67, 270f | 0.03 (−0.23,0.29) | 0.818 | ||
≥2 | 30, 52f | 0.36 (0.04,0.67) | 0.027 | ||
Frequency of sex | |||||
Once/month or less | 14, 118g | ref | ref | ||
Several times/month | 36, 131g | 0.17 (−0.02,0.36) | 0.074 | 0.13 (−0.05,0.31) | 0.164 |
Several times/week | 50, 111g | 0.30 (0.10,0.51) | 0.003 | 0.20 (0.00,0.41) | 0.049 |
Sex with NPh | |||||
No | 60, 300 | ref | ref | ||
Yes | 40, 60 | 0.49 (0.30,0.68) | <0.001 | 0.41 (0.21,0.60) | <0.001 |
Sexual practices with an FSPi | |||||
Any receptive oral vaginal sex | |||||
Noj,e | 15, 138 | ref | ref | ||
Yes | 85, 221 | 0.24 (0.08,0.40) | 0.003 | 0.15 (−0.02,0.31) | 0.076 |
Any digital anal sex | |||||
Noj,e | 77, 317 | ref | |||
Yes | 23, 41 | 0.32 (0.08,0.57) | 0.010 | ||
Sharing of sex toyse | |||||
No toys/washed/condoms usedj | 58, 272 | ref | |||
Unwashed | 42, 87 | 0.18 (−0.00,0.37) | 0.051 | ||
Sexual practices with an MSPk | |||||
Any vaginal sex | |||||
Nol, e | 86, 321 | ref | |||
Yes | 14, 38 | 0.07 (−0.21,0.35) | 0.637 | ||
Self-reported symptoms | |||||
Self-reported abnormal vaginal discharge and/or odour | |||||
No | 72, 317 | ref | |||
Yes | 28, 43 | 0.32 (0.09,0.55) | 0.007 |
Abbreviations: BV, bacterial vaginosis; SP, sexual partner (may refer to FSP or MSP); NP, new partner (may refer to FSP or MSP); FSP, female sexual partner; MSP, male sexual partner
Missing data for variables included in this analysis occurred in <0.5% of intervals.
aUnivariate GEE linear regression, where participant ID is panel variable. The regression coefficient represents the mean difference of Shannon diversity between the reference and comparison group/s for each characteristic/practice investigated.
bMultivariable GEE linear regression, where participant ID is panel variable.
cLongitudinal characteristics were measured as any exposure over the prior study interval (~90 days). No significant associations were identified between Shannon diversity and either hormonal contraceptive use or recent menses.
dThere was no dose-response relationship between smoking and Shannon diversity.
eMissing data from a maximum of two intervals for some variables.
fFor women reporting different numbers of sexual partners in two or more intervals, the category representing the highest number of sexual partners has been used to calculate n women reporting exposure.
gFor women reporting different frequencies of sexual activity in two or more intervals, the most frequent category has been used to calculate n women reporting exposure.
hSex with a new partner with who first sexual contact was within 90 days.
iNo significant associations were identified between Shannon diversity and the following sexual practices with an FSP: Any digital vaginal sex from an FSP, any receptive oral anal sex from an FSP and current FSP with BV symptoms. These practices have been left out to simplify the table.
jOr did not have a FSP.
kNo significant associations were identified between Shannon diversity and the following sexual practices with an MSP: Condoms used for vaginal sex, vaginal sex after anal sex, any receptive oral vaginal sex from an MSP, any digital vaginal sex from an MSP, any anal sex from an MSP. These practices have been left out to simplify the table.
lOr did not have a MSP.